Search
for

    GlossaryTelogen Ratio

    proportion of hair follicles in the resting phase

    The Telogen Ratio refers to the proportion of hair follicles in the telogen phase, which is the resting phase of the hair growth cycle. In a healthy scalp, about 10-15% of hair follicles are typically in this phase. A higher telogen ratio can indicate hair loss conditions such as telogen effluvium, where a larger number of hairs are shed.

    Related Terms

    Learn

    5 / 801 results

    Research

    5 / 1000+ results

    Community Join

    5 / 708 results

      community Why haven’t we seen anything about this

      in Research/Science  18 upvotes 5 years ago
      A double blind, placebo-controlled study that looked into the potential effectiveness of topical fluridil for treating male androgenetic alopecia, showing increased anagen to telogen ratios with no reported side effects on libido or sexual performance.

      community Hair loss treatments rated (by gpt-4)

      in Research/Science  248 upvotes 3 years ago
      Rating treatments for hair loss, with the help of GPT-4, according to efficacy, evidence and tolerability; a combination of chemicals from research papers, custom compounds, and some suggestions from other users were included.

      community My Theory Of Androgenic Alopecia

      in Research/Science  19 upvotes 4 months ago
      Hair loss is linked to cellular physiology and the IGF-1 to TGF-B1 ratio, not just androgen sensitivity. The theory lacks evidence, while finasteride and minoxidil are effective treatments.

      community is there anything that stops hair loss?

      in Female  8 upvotes 1 year ago
      A user is experiencing rapid hair loss and has been diagnosed with telogen effluvium by multiple dermatologists, but doubts the diagnosis due to the severity and speed of the hair loss. They are considering various treatments like spironolactone, estradiol, and possibly finasteride, while also exploring the possibility of hormonal imbalances or autoimmune issues.

      community HLT Megathread on HMI-115 (key takeaways in comments)

      in Research/Science  39 upvotes 3 years ago
      HMI-115, a newly discovered hair loss treatment that could potentially be effective for those with diffuse thinning and telogen effluvium. It is based on prolactin receptor antagonist signaling and has already undergone Phase I trials in women, with potential commercialization by 2027.